Sign in

NCT06296368Recruiting

DISCOVERY: Evaluating a Decision Support Tool for Adults Seen in Hematology/Oncology Clinics

Source: ClinicalTrials.gov · Last updated 14 Aug 2026

Brief summary (registry, in English)

The purpose of this study is to evaluate whether a novel decision support tool called PRIME (Preference Reporting to Improve Management and Experience), which combines values-elicitation with tailored feedback to patients and providers, improves patient-reported values-concordance of initial treatment decisions compared to usual care.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
500 (estimated)
First submitted
28 Feb 2024
Start date
21 Jun 2024
Primary completion date
1 Sept 2028
Lead sponsor
UNC Lineberger Comprehensive Cancer Center
NCT number
NCT06296368

What you commit to

  • Study type: Interventional
  • Planned participants: 500
  • From 21 Jun 2024 to the primary completion date, 1 Sept 2028
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • 1\. Dementia, altered mental status, or psychiatric condition that would prohibit the understanding or rendering of informed consent or participation in the intervention.

Other

  • All subjects meeting any of the exclusion criteria listed below at baseline will be excluded from study participation:

Who the study is looking for

  • Written or verbal informed consent obtained to participate in the study and HIPAA authorization for the release of personal health information.
  • Subjects are willing and able to comply with study procedures based on the judgment of the investigator.
  • Age ≥ 60 years at the time of consent.
  • New patient to either the hematologic malignancies clinic or the bone marrow transplant/cellular therapy clinic.

Age in the registry: 60 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Lineberger Comphrehensive Cancer Center at University of North Carolina
Coordinator of this site? Confirm its status
Chapel HillUnited StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.